Ralstonia pickettii is a species of Gram-negative, aerobic, non-fermenting, rod-shaped bacteria belonging to the genus Ralstonia. It is recognized primarily as an opportunistic human pathogen, particularly in healthcare settings.
Overview Ralstonia pickettii is an environmental bacterium commonly found in water, soil, and moist environments. In clinical contexts, it is increasingly isolated from hospital water systems, disinfectants, saline solutions, and medical devices. It is known to cause a variety of nosocomial infections, especially in immunocompromised patients or those with underlying conditions. Infections can include bacteremia, respiratory tract infections (e.g., pneumonia), urinary tract infections, wound infections, and infections related to contaminated medical products or devices. A significant characteristic of R. pickettii is its intrinsic resistance to a broad range of antibiotics, which can complicate treatment.
Etymology/Origin The genus name Ralstonia was established in 1995 and named in honor of E. Ralston, a microbiologist who contributed to the study of pseudomonads. The species epithet pickettii was given in honor of M.J. Pickett, who first isolated and described the organism in 1959, initially classifying it under the genus Pseudomonas as Pseudomonas pickettii. It was later reclassified to the genus Ralstonia following phylogenetic analysis.
Characteristics
- Morphology and Metabolism: R. pickettii are Gram-negative, aerobic, motile rods. They are non-fermentative, meaning they do not produce acid from glucose fermentation, distinguishing them from fermentative Gram-negative bacteria. They are often oxidase-positive and catalase-positive.
- Habitat: It is ubiquitous in natural environments, including fresh water, soil, and plant rhizospheres. In artificial environments, it can thrive in distilled water, sterile water, saline solutions, and even some disinfectants, making it a persistent contaminant in hospitals and pharmaceutical industries.
- Pathogenicity: As an opportunistic pathogen, R. pickettii primarily affects individuals with compromised immune systems, chronic illnesses, or those undergoing invasive medical procedures. Outbreaks are frequently linked to contaminated medical devices, intravenous fluids, or hospital water systems. The ability to form biofilms on surfaces contributes to its persistence and resistance to eradication.
- Antimicrobial Resistance: A defining feature of R. pickettii is its high level of intrinsic resistance to numerous antimicrobial agents. This includes many beta-lactam antibiotics (e.g., penicillins, cephalosporins), carbapenems, and aminoglycosides. This multidrug resistance is a significant challenge in clinical management and often necessitates the use of alternative antibiotics or combination therapy.
- Identification: Identification typically involves conventional biochemical tests, but molecular methods such as 16S rRNA gene sequencing are increasingly used for accurate and rapid identification due to phenotypic similarities with other non-fermenting Gram-negative bacteria.
Related Topics
- Nosocomial infections
- Opportunistic pathogens
- Antimicrobial resistance
- Environmental microbiology
- Waterborne pathogens
- Biofilm formation
- Ralstonia solanacearum (a closely related plant pathogen)